Baiyunshan Jinge raw material production was approved and won the first place of Viagra in China

After the expiration of Pfizer vanico (commonly known as "Viagra") patent, Baiyunshan (600332) "Viagra" -- "Jinge" has always attracted social attention Following the approval of "Jinge" preparation production approval on July 30, and the approval of "Jinge" raw material production approval on August 21, now the preparation and raw material production approval are both in the certification stage There is no doubt that Baiyunshan "Jinge" won the first place of "Viagra" in China The relevant personnel of the company said in an interview with reporters that the strength of Guangyao group is to be taken into consideration The listing place of "Jinge" is well prepared, and it is expected to be successfully listed and occupy a considerable market share in the year "Jinge" raw material production approval completed the company said it is expected to be on the market within the year Li Chuyuan, chairman of Guangyao group, revealed on Weibo that "Viagra" under Baiyunshan of Guangyao is named "Jinge" On the evening of August 22, Baiyunshan of Guangyao officially announced the approval notice of the completion of the above "Jinge" raw material production approval document In an interview with the reporter of investment express, the relevant person in charge of Guangyao group office said that it is of great significance to obtain the approval documents for the production of "Jinge" raw materials On the one hand, it means that the raw materials and preparations of "Jinge" in Baiyunshan have been approved, and the listing has entered the countdown The following specific process time is "making and stamping, express delivery to Guangdong Provincial Drug Administration, and then transfer to pharmaceutical enterprises" After the approved license is obtained, the company will hold a press conference in public; the company will promote the relevant work as soon as possible, and realize the production and listing of "Jinge" as soon as possible If there is no accident, the product can be produced and listed within the year According to its disclosure, Baiyunshan is currently setting up a sales team to carry out preliminary work such as overall strategic layout, market research, production capacity preparation, etc., and make preparations for the listing place of "Jinge" with the strength of Guangyao group Previously, according to related research reports of Guoxin Securities, China's ed (male erectile dysfunction) market was about 2 billion yuan in 2012, but 80% of the patients did not receive treatment, which means that the potential market for ED in 2012 was about 10 billion yuan The market has been looking forward to the opportunities for generic companies after the expiration of "Viagra" patent After the expiration of "Viagra" patent in South Korea and Thailand, the rapid market share of generic drugs provides a good case for the Chinese market It is understood that the raw material of Baiyunshan Jinge was applied by Guangzhou Baiyunshan Chemical Pharmaceutical Co., Ltd., a subsidiary of Guangzhou Baiyunshan Pharmaceutical Co., Ltd Yesterday evening, a reporter from the investment express found on the website of the administrative acceptance service center of the State Food and drug administration that the approval of the raw material production approval document of Jinge had been changed from "in approval" to "approval completed pending certification" at 9:10 on August 21, 2014 Before that, at 9:08 a.m on July 30, the Jinge preparation declared by Baiyunshan Pharmaceutical General Factory of Guangzhou Baiyunshan, a subordinate enterprise of Guangzhou Baiyunshan Pharmaceutical Co., Ltd., had also been approved and was in the "pending certification" state As a result, the raw materials and preparations of Baiyunshan "Jinge" have been approved, and the first one in China will be listed soon Affected by this news, Baiyunshan A-share started in the afternoon, rising 2.17 yuan throughout the day, with a final increase of 8.51% The "good news" announced at the company level only after the closing, but the stock price has changed significantly in the session, is it related to information disclosure? In response to the reporter from the investment express, the person in charge of brand publicity in Guangyao said that "information leakage" does not exist After the raw materials of the products are approved, the State Administration of drug administration will publish the approval process status on the website of the administrative acceptance service center of the State Food and Drug Administration for the first time, rather than notifying the pharmaceutical enterprises first Anyone can be in the State Food and drug administration Search and browse on the website of the administrative acceptance service center of the general administration Perhaps it is true that "early birds have worms to eat." the reporter of investment express observed that as early as 10:56 a.m yesterday, shareholders "exterminate fake loot" posted in the stock bar of a well-known financial website: "major news: both applications of" Jinge "have been approved", and the original posted "Jinge" on the website of the administrative acceptance service center of the State Food and drug administration The newly updated approval acceptance status - "approval completed - Certificate to be prepared" and "status start time 2014-8-219:10:27" When this "early bird like investor posted, Baiyunshan's stock price was still at the bottom of yesterday's whole day, with an increase of less than 1%, and then began to move up In the afternoon, he once felt the limit, closing at 27.68 yuan, with the volume of trading several times higher than that of the past, more than 530000 Will become the global "Viagra" raw material supplier "Jinge" to be the top domestic insiders said that because the raw materials and preparations are produced by themselves, and the industrial chain is seamlessly connected, Baiyunshan "Jinge" will have more price advantages in the future As the largest pharmaceutical industry enterprise in China, Baiyunshan Jinge will become Pfizer's most powerful "enemy" in the future market competition Yao Yi, an analyst at Huatai Securities, believes that Baiyunshan Pharmaceutical business has a large base and limited future growth flexibility However, "Viagra" will bring vitality to the pharmaceutical business of the company With the help of the advantages of the company's terminal OTC channel, the company will quickly distribute goods, which is expected to become a large variety with an output value of 500-1 billion yuan in the future Zhejiang stock investors are more optimistic about the prediction and analysis The market scale of "Kingway" will be much larger than that of Viagra There are several reasons: first, Viagra is too expensive, with a daily consumer product of 100 yuan, and few people consume it; second, Viagra is still Viagra, and the brand is not moving; third, although the brand of "Kingway" is the second largest, it is a fast daily consumer product for more than one billion people Fourth, the price of "Jinge" is cheap and close to the local atmosphere In addition, according to the introduction of Baiyun Mountain of Guangyao to the reporter of investment express, as the upstream of chemical drugs, the API industry has always been the key layout industry of Baiyun Mountain in the Dayan pharmaceutical industry The approval of the "Jinge" raw material production approval not only means that "Jinge" will be listed soon, but also means that Baiyunshan will become the supplier of "Viagra" raw materials In the future, in addition to meeting the production demand of "Jinge", it will also become a raw material supplier to provide raw materials for the production enterprises of "Viagra" in other countries It is understood that in the past 10 years, more than 10 enterprises, including Changshan Co., Ltd., Jiangsu Lianhuan Pharmaceutical Co., Ltd., Sichuan Yuanji Pharmaceutical Co., Ltd., Zhuhai Biochemical Pharmaceutical Co., Ltd., Beijing Zhongtian Kangda Pharmaceutical Co., Ltd., Guangdong biochemical pharmaceutical engineering technology development center, etc., have submitted the "Viagra" generic application However, in several enterprises, Baiyunshan's "Jinge" advantage is the most obvious - quality and technology advantage, pharmacy channel advantage, brand advantage This time, the approval is undoubtedly the "top card".